Guidelines on the treatment of chronic coinfection by trypanosoma cruzi and HIV outside endemic areas

HIV Clinical Trials

Volumn 12, Issue 6, 2011, Pages 287-298

  Pérez Molina, José ^a   Rodríguez Guardado, Azucena ^b   Soriano, Antonio ^c   Pinazo, María Jesús ^d   Carrilero, Bartolomé ^e   García Rodríguez, Magdalena ^f   Salas, Joaquín ^g   Torrús, Diego ^h   Soler Ferrer, Cristina ⁱ   Puente, Sabino ^j   Haro González, Juan ^k   Martín Rabadán, Pablo ^l   Gascon, Joaquim ^d  

^a INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^g HOSPITAL DE PONIENTE   (Spain)

^h HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

ⁱ Hospital de Sta Caterina   (Spain)

^j HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^l HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

more..

Author keywords

Chagas disease; emerging infections; guideline; HIV coinfection; imported infections; opportunistic infections; Trypanosoma cruzi

Indexed keywords

ABACAVIR; BENZNIDAZOLE; DIDANOSINE; EFAVIRENZ; FLUCONAZOLE; FOSAMPRENAVIR; ITRACONAZOLE; KETOCONAZOLE; NIFURTIMOX; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; POSACONAZOLE; PROTEINASE INHIBITOR; RALTEGRAVIR; STAVUDINE; ZIDOVUDINE;

ANOREXIA; ARTICLE; BLOOD SMEAR; BLOOD TOXICITY; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; CHAGAS DISEASE; CLINICAL FEATURE; COMORBIDITY; DIZZINESS; DRUG TOLERABILITY; GASTROINTESTINAL PAIN; HEARTBURN; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INSOMNIA; LEUKOPENIA; MEASLES LIKE RASH; MORTALITY; NAUSEA; NEUROPATHY; NEUROTOXICITY; PARASITEMIA; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREGNANT WOMAN; PRIORITY JOURNAL; PROPHYLAXIS; PRURITUS; SIDE EFFECT; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TREATMENT DURATION; VIRUS LOAD; VOMITING; WEIGHT REDUCTION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CHAGAS DISEASE; CHRONIC DISEASE; COINFECTION; ENDEMIC DISEASES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RECURRENCE; TRYPANOCIDAL AGENTS;

EID: 84255188708     PISSN: 15284336     EISSN: 19455771     Source Type: Journal    
DOI: 10.1310/hct1206-287     Document Type: Article

References (97)

1. Organización Panamericana de la salud (OPS/OMS). Estimación cuantitativa de la Enfermedad de Chagas en las Américas. OPS/HDM/CD/425-06. Montevideo, Uruguay; 2006.
2. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375:1388-1402.
3. Control and prevention of Chagas disease in Europe. Report of a WHO Informal Consultation (jointly organized by WHO headquarters and the WHO Regional Office for Europe). Geneva, Switzerland; December 17-18, 2009. WHO/HTM/NTD/IDM/2010.1. 2010.
4. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115:14-21.
5. Instuto Nacional de Estadística. http://www.ine.es/jaxi/tabla.do.
6. Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 2010;115:22-27.
7. Munoz J, Gomez i Prat J, Gallego M, et al. Clinical profi le of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop. 2009;111:51-55.
8. Rodriguez-Guardado A, Alvarez VA, Rodriguez Perez M, et al. Screening for Chagas' disease in HIV-positive immigrants from endemic areas. Epidemiol Infect. 2010:1-5.
9. Pérez-Ayala A, Pérez-Molina JA, Norman F, et al. Chagas disease in Latin American migrants: a Spanish challenge [published online ahead of print December 14, 2010]. Clin Microbiol Infect. 2011;17(7):1108-1113. doi: 10.1111/j.1469-0691.2010.03423.x.
10. AIDS epidemic update. UNAIDS/09.36E / JC1700E. 2009. http://data.unaids. org/pub/Report/2009/JC1700-Epi-Update-2009-en.pdf.
11. Vigilancia epidemiológica del VIH en España. Valoración de los nuevos diagnósticos de VIH en España a partir de los sistemas de notificación de casos de la CCAA. Periodo 2003-2008. Actualización 30 de junio de 2009. www.msps.es/ciudadanos/ enfLesiones/enfTransmisibles/sida/vigilancia/NuevosdiagVIH2009.pdf. 2009.
12. Almeida EA, Lima JN, Lages-Silva E, et al. Chagas' disease and HIV co-infection in patients without effective antiretroviral therapy: prevalence, clinical presentation and natural history. Trans R Soc Trop Med Hyg. 2010;104:447-452.
13. Diez MS, Nocito I, de Frade AR, Cappello SG, Guillen SM, Montero A. [Serological evidence of cytomegalovirus, hepatitis B and C, Epstein-Barr virus, Toxoplasma gondii, Trypanosoma cruzi and Treponema pallidum in HIV infected patients]. Medicina (B Aires). 2001;61:378-380. (Pubitemid 33040199)
14. Dolcini G, Ambrosioni J, Andreani G, Pando MA, Martinez Peralta L, Benetucci J. [Prevalence of human immunodeficiency virus (HIV)-Trypanosoma cruzi co-infection and injectable-drugs abuse in a Buenos Aires health center]. Rev Argent Microbiol. 2008;40:164-166.
15. Kish MA. Guide to development of practice guidelines. Clin Infect Dis. 2001;32:851-854. (Pubitemid 32524817)
16. Karp CL, Auwaerter PG. Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens. Clin Infect Dis. 2007;45:1208-1213. (Pubitemid 47580323)
17. Diazgranados CA, Saavedra-Trujillo CH, Mantilla M, Valderrama SL, Alquichire C, Franco-Paredes C. Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis. 2009;9:324-330.
18. Sartori AM, Neto JE, Nunes EV, et al. Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients. J Infect Dis. 2002;186:872-875. (Pubitemid 35013446)
19. Idemyor V. Human immunodeficiency virus (HIV) and malaria interaction in sub-Saharan Africa: the collision of two Titans. HIV Clin Trials. 2007;8:246-253. (Pubitemid 47327462)
20. Kjetland EF, Ndhlovu PD, Gomo E, et al. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS. 2006;20:593-600. (Pubitemid 43731604)
21. Cordova E, Boschi A, Ambrosioni J, Cudos C, Corti M. Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007. Int J Infect Dis. 2008;12:587-592.
22. Del Castillo M, Mendoza G, Oviedo J, Perez Bianco RP, Anselmo AE, Silva M. AIDS and Chagas' disease with central nervous system tumor-like lesion. Am J Med. 1990;88:693-694. (Pubitemid 20192292)
23. Ferreira MS, Nishioka Sde A, Silvestre MT, Borges AS, Nunes-Araujo FR, Rocha A. Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin Infect Dis. 1997;25: 1397-1400. (Pubitemid 28022678)
24. Gallo P, Fabiao Neto OM, Suarez JM, Borba RP. Acute central nervous system infection by Trypanosoma cruzi and AIDS. Arq Neuropsiquiatr. 1992;50:375-377.
25. Rocha A, de Meneses AC, da Silva AM, et al. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg. 1994;50:261-268. (Pubitemid 24110478)
26. Sartori AM, Ibrahim KY, Nunes Westphalen EV, et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol. 2007;101:31-50. (Pubitemid 47488082)
27. Sartori AM, Caiaffa-Filho HH, Bezerra RC, do SGC, Lopes MH, Shikanai-Yasuda MA. Exacerbation of HIV viral load simultaneous with asymptomatic reactivation of chronic Chagas' disease. Am J Trop Med Hyg. 2002;67:521-523. (Pubitemid 35403169)
28. Organización Panamericana de la Salud. Defi nición de la OMS de caso de infección por el VIH a efectos de vigilancia y revisión de la estadificación clínica y de la clasificación inmunológica de la enfermedad relacionada con el VIH en adultos y niños. 2009. OPS/FCH/HI/04-09.E.
29. Sartori AM, Shikanai-Yasuda MA, Amato Neto V, Lopes MH. Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease causing cardiac disease in three patients. Clin Infect Dis. 1998;26:177-179. (Pubitemid 28068173)
30. Almeida EA, Ramos Junior AN, Correia D, Shikanai-Yasuda MA. [Brazilian Network of Attention and Studies on Trypanosoma cruzi/HIV co-infection and others immunossupression conditions]. Rev Soc Bras Med Trop. 2009;42:605-608.
31. Sica RE, Gargiullo G, Papayanis C. Tumour-like chagasic encephalitis in AIDS patients: an atypical presentation in one of them and outcome in a small series of cases. Arq Neuropsiquiatr. 2008;66:881-884.
32. Pagano MA, Segura MJ, Di Lorenzo GA, et al. Cerebral tumor-like American trypanosomiasis in acquired immunodeficiency syndrome. Ann Neurol. 1999;45:403-406. (Pubitemid 29120049)
33. Sartori AM, Lopes MH, Benvenuti LA, et al. Reactivation of Chagas' disease in a human immunodeficiency virusinfected patient leading to severe heart disease with a late positive direct microscopic examination of the blood. Am J Trop Med Hyg. 1998;59:784-786. (Pubitemid 28524538)
34. [Recommendations for diagnosis, treatment and follow-up of the Trypanosoma cruzi: human immunodeficiency virus co-infection]. Rev Soc Bras Med Trop. 2006;39:392-415.
35. Concetti H, Retegui M, Perez G, Perez H. Chagas' disease of the cervix uteri in a patient with acquired immunodefi -ciency syndrome. Hum Pathol. 2000;31:120-122. (Pubitemid 30054397)
36. dos Santos Sde S, Almeida GM, Monteiro ML, et al. Ocular myositis and diffuse meningoencephalitis from Trypanosoma cruzi in an AIDS patient. Trans R Soc Trop Med Hyg. 1999;93:535-536. (Pubitemid 29495842)
37. Iliovich E, Lopez R, Kum M, Uzandizaga G. [Spontaneous chagasic peritonitis in a patient with AIDS]. Medicina (B Aires). 1998;58:507-508. (Pubitemid 128524821)
38. Oelemann W, Velasquez JN, Carnevale S, Besasso H, Teixeira MG, Peralta JM. Intestinal Chagas' disease in patients with AIDS. AIDS. 2000;14:1072-1073. (Pubitemid 30336076)
39. Sartori AM, Sotto MN, Braz LM, et al. Reactivation of Chagas disease manifested by skin lesions in a patient with AIDS. Trans R Soc Trop Med Hyg. 1999;93:631-632. (Pubitemid 30015791)
40. Ferreira MS, Nishioka Sde A, Rocha A, et al. Acute fatal Trypanosoma cruzi meningoencephalitis in a human immunodeficiency virus-positive hemophiliac patient. Am J Trop Med Hyg. 1991;45:723-727.
41. Solari A, Saavedra H, Sepulveda C, et al. Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS. Clin Infect Dis. 1993;16: 255-259. (Pubitemid 23047425)
42. Valerga M, Bases O, Martin M, Papucci T. [Multifocal encephalitis in an AIDS patient]. Enferm Infecc Microbiol Clin. 2005;23:569-570. (Pubitemid 41695916)
43. Corti M, Yampolsky C. Prolonged survival and immune reconstitution after chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome. Rev Soc Bras Med Trop. 2006;39:85-88.
44. Lopez MO. [Three-year survival of a patient with HIV and chagasic meningoencephalitis: case report]. Rev Chilena Infectol. 2010;27:160-164.
45. Flores-Chavez M, De Fuentes I, Gárate T, Cañavate C. Diagnóstico de laboratorio de la enfermedad de Chagas importada. Enferm Infecc Microbiol Clin. 2007;25 (Suppl 3):29-37.
46. Murcia L, Carrilero B, Munoz MJ, Iborra MA, Segovia M. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country. J Antimicrob Chemother. 2010;65:1759-1764.
47. Schijman AG, Bisio M, Orellana L, et al. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis. 2011;5:e931.
48. Gascon J. [Diagnosis and treatment of imported Chagas disease]. Med Clin (Barc). 2005;125:230-235. (Pubitemid 41158270)
49. Di Lorenzo GA, Pagano MA, Taratuto AL, Garau ML, Meli FJ, Pomsztein MD. Chagasic granulomatous encephalitis in immunosuppressed patients. Computed tomography and magnetic resonance imaging findings. J Neuroimaging. 1996;6:94-97. (Pubitemid 26127341)
50. Verdu J, De Paz F, Castano V, Torrus D, Reus S. Reactivation of Chagas disease with central nervous system involvement: peripheral blood smear evidence. Int J Infect Dis. 2009;13:e527-8.
51. Burgos JM, Diez M, Vigliano C, et al. Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation. Clin Infect Dis. 2010;51:4 85-495.
52. Corti M, Trione N, Corbera K, Vivas C. [Chagas disease: another cause of cerebral mass occurring in patients with acquired immunodeficiency syndrome]. Enferm Infecc Microbiol Clin. 2000;18:194-196.
53. Lages-Silva E, Ramirez LE, Silva-Vergara ML, Chiari E. Chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome: diagnosis, follow-up, and genetic characterization of Trypanosoma cruzi. Clin Infect Dis. 2002;34:118-123. (Pubitemid 33152676)
54. Lazo JE, Meneses AC, Rocha A, et al. [Toxoplasmic and chagasic meningoencephalitis in patients with human immunodeficiency virus infection: anatomopathologic and tomographic differential diagnosis]. Rev Soc Bras Med Trop. 1998;31:163-71.
55. Oddo D, Casanova M, Acuna G, Ballesteros J, Morales B. Acute Chagas' disease (Trypanosomiasis americana) in acquired immunodeficiency syndrome: report of two cases. Hum Pathol. 1992;23:41-44.
56. Almeida EA, Silva EL, Guariento ME, Souza ML, Aoki FH, Pedro Rde J. [Fatal evolution of Chagas'disease/AIDS co-infection: diagnostic difficulties between myocarditis reactivation and chronic chagasic myocardiopathy]. Rev Soc Bras Med Trop. 2009;42:199-202.
57. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: asystematic review. JAMA. 2007;298:2171-2181. (Pubitemid 350106656)
58. Perez-Molina JA, Perez-Ayala A, Moreno S, Fernandez-Gonzalez MC, Zamora J, Lopez-Velez R. Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis. J Antimicrob Chemother. 2009;64:1139-1147.
59. Rodriques Coura J, de Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz. 2002;97:3-24. (Pubitemid 135746197)
60. Viotti R, Vigliano C, Lococo B, et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med. 2006;144:724-734. (Pubitemid 46780632)
61. Reyes PA, Vallejo M. Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection). Cochrane Database Syst Rev. 2005:CD004102.
62. Murta SM, Gazzinelli RT, Brener Z, Romanha AJ. Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Mol Biochem Parasitol. 1998;93:203-214. (Pubitemid 28277058)
63. Villarreal D, Nirde P, Hide M, Barnabe C, Tibayrenc M. Differential gene expression in benznidazole-resistant Trypanosoma cruzi parasites. Antimicrob Agents Chemother. 2005;49:2701-2709. (Pubitemid 40917581)
64. Castro JA, de Mecca MM, Bartel LC. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Hum Exp Toxicol. 2006;25:471-479. (Pubitemid 44384589)
65. Pinazo MJ, Munoz J, Posada E, et al. Tolerance of benznidazole in treatment of Chagas' disease in adults. Antimicrob Agents Chemother. 2010;54:4896-4899.
66. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58:1-207; quiz CE1-4.
67. [2008 prevention of opportunistic infections in HIV-infected adolescents and adults guidelines. Recommendations of GESIDA/National AIDS Plan AIDS Study Group (GESIDA) and National AIDS Plan.]. Enferm Infecc Microbiol Clin. 2008;26:437-464.
68. Jackson Y, Alirol E, Getaz L, Wolff H, Combescure C, Chappuis F. Tolerance and safety of nifurtimox in patients with chronic chagas disease. Clin Infect Dis. 2010;51:e69-75.
69. de Almeida EA, Silva EL, Guariento ME, Aoki FH, Pedro Rde J. Aetiological treatment with itraconazole or ketoconazole in individuals with Trypanosoma cruzi/HIV coinfection. Ann Trop Med Parasitol. 2009;103:471-476.
70. Pinazo MJ, Espinosa G, Gallego M, Lopez-Chejade PL, Urbina JA, Gascon J. Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus. Am J Trop Med Hyg. 2010;82:583-587.
71. Boffito M, Acosta E, Burger D, et al. Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs. Antivir Ther. 2005;10:469-477. (Pubitemid 41059193)
72. Rodriguez-Guardado A, Tuset M, Asensi V, Miro JM. [Human immunodeficiency virus and Chagas disease coinfection treated successfully with benznidazole and a raltegravir-based antiretroviral regimen: a case report]. Med Clin (Barc). 2010;137:278-279.
73. Dooley KE, Flexner C, Andrade AS. Drug interactions involving combination antiretroviral therapy and other anti-infective agents: repercussions for resource-limited countries. J Infect Dis. 2008;198:948-961.
74. Guía para vigilancia, prevención, control y manejo clínico de la Enfermedad de Chagas aguda transmitida por alimentos (PAHO/HSD/CD/539.09). Rio de Janeiro: PANAFTOSA-VP/ OPAS/OMS: Organización Panamericana de la salud; 2009.
75. Pinazo MJ, Miranda B, Rodriguez-Villar C, et al. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev (Orlando). 2011;25: 91-101.
76. REAL DECRETO 1088/2005, de 16 de septiembre, por el que se establecen los requisitos técnicos y condiciones mínimas de la hemodonación y de los centros y servicios de transfusión. Ministerio de Sanidad y Consumo. In: Boletin Oficial del Estado, número 225; 2005.
77. Villar JC, Marin-Neto JA, Ebrahim S, Yusuf S. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection. Cochrane Database Syst Rev. 2002:CD003463.
78. Perez-Ramirez L, Barnabe C, Sartori AM, et al. Clinical analysis and parasite genetic diversity in human immunodeficiency virus/Chagas' disease coinfections in Brazil. Am J Trop Med Hyg. 1999;61:198-206. (Pubitemid 29380249)
79. Galhardo MC, Martins IA, Hasslocher-Moreno A, et al. [Reactivation of Trypanosoma cruzi infection in patients with acquired immunodeficiency syndrome]. Rev Soc Bras Med Trop. 1999;32:291-294. (Pubitemid 29277905)
80. Munoz J, Coll O, Juncosa T, et al. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis. 2009;48:1736-1740.
81. Paricio-Talayero JM, Benlloch-Muncharaz MJ, Collar-del-Castillo JI, et al. [Epidemiological surveillance of verticallytransmitted Chagas disease at three maternity hospitals in the Valencian Community]. Enferm Infecc Microbiol Clin. 2008;26:609-613.
82. Soriano Arandes A, Munoz Gutierrez J, Verges Navarro M, Castells Domenech C, Portus Vinyeta M, Gascon Brustenga J. Prevalence of Chagas disease in the Latin American immigrant population in a primary health centre in Barcelona (Spain). Acta Trop. 2009;112:228-230.
83. Brutus L, Castillo H, Bernal C, et al. Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease. Am J Trop Med Hyg. 2010;83:1044-1047.
84. Sosa-Estani S, Cura E, Velazquez E, Yampotis C, Segura EL. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission. Rev Soc Bras Med Trop. 2009;42:484-487
85. Bisio M, Cura C, Duffy T, et al. Trypanosoma cruzi discrete typing units in Chagas disease patients with HIV coinfection. Rev Biomed. 2009;20:166-178.
86. Freilij H, Altcheh J, Muchinik G. Perinatal human immunodeficiency virus infection and congenital Chagas' disease. Pediatr Infect Dis J. 1995;14:161-162.
87. Nisida IV, Amato Neto V, Braz LM, Duarte MI, Umezawa ES. A survey of congenital Chagas' disease, carried out at three health institutions in Sao Paulo City, Brazil. Rev Inst Med Trop Sao Paulo. 1999;41:305-311.
88. Scapellato PG, Bottaro EG, Rodriguez-Brieschke MT. Mother-child transmission of Chagas disease: Could coinfection with human immunodeficiency virus increase the risk? Rev Soc Bras Med Trop. 2009;42:107-109.
89. Bern C, Verastegui M, Gilman RH, et al. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis. 2009;49:1667-1674.
90. Andreani G, Celentano AM, Solana ME, et al. Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi. PLoS One. 2009;4:e8246.
91. Dolcini GL, Solana ME, Andreani G, et al. Trypanosoma cruzi (Chagas' disease agent) reduces HIV-1 replication in human placenta. Retrovirology. 2008;5:53.
92. de Toranzo EG, Masana M, Castro JA. Administration of benznidazole, a chemotherapeutic agent against Chagas disease, to pregnant rats. Covalent binding of reactive metabolites to fetal and maternal proteins. Arch Int Pharmacodyn Ther. 1984;272:17-23. (Pubitemid 15210649)
93. Gorla NB, Ledesma OS, Barbieri GP, Larripa IB. Assessment of cytogenetic damage in chagasic children treated with benznidazole. Mutat Res. 1988;206:217-220.
94. Gorla NB, Ledesma OS, Barbieri GP, Larripa IB. Thirteenfold increase of chromosomal aberrations non-randomly distributed in chagasic children treated with nifurtimox. Mutat Res. 1989;224:263-267. (Pubitemid 19248960)
95. Bittencourt AL, Sadigursky M, Da Silva AA, et al. Evaluation of Chagas' disease transmission through breastfeeding. Mem Inst Oswaldo Cruz. 1988;83:37-39.
96. Bittencourt AL. Possible risk factors for vertical transmission of Chagas' disease. Rev Inst Med Trop Sao Paulo. 1992;34:403-408.
97. Recomendaciones de la SPNS/GESIDA/SEGO/AEP para el seguimiento de la infección por el VIH con relación a la reproducción, el embarazo y la prevención de la transmisión vertical. (Diciembre 2007). www.gesida.seimc.org/pcientifica/index.asp (consultado el 1 de noviembre de 2010). 2007.